Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility
Immunity, Inflammation and Disease · 2026-05 · 14 (5)
DOI: 10.1002/iid3.70426 ↗Kurz gefasst
Leserbrief in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 21.05.2026. Verfasst von Aditya K Panda. Beteiligte Einrichtung: ImmGen EvSys Lab, BT-113, Department of Biotechnology, Berhampur University, Berhampur, Odisha, India. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- ImmGen EvSys Lab, BT-113, Department of Biotechnology, Berhampur University, Berhampur, Odisha, India.
- Centre of Excellence on Bioprospecting of Ethno-Pharmaceuticals of Southern Odisha (CoE-BESO), Berhampur University, Berhampur, Odisha, India.
ORCID-Profile: Aditya K Panda
Zitieren
APA
Panda, A. K. (2026). Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility. Immunity, Inflammation and Disease, 14(5). https://doi.org/10.1002/iid3.70426
Vancouver
Panda AK. Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility. Immunity, Inflammation and Disease. 2026;14(5). doi:10.1002/iid3.70426
BibTeX
@article{Panda2026,
author = {Panda, Aditya K},
title = {Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {5},
doi = {10.1002/iid3.70426}
}
EUVIMED